EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Complement C3 Genotype Variants and Risk of Lung Cancer Mortality

Poul Suadicani, Hans Ole Hein, Finn Gyntelberg

ISRN Pulmonology · 2011

DOI: 10.5402/2011/423571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Pulmonology, 2011. Verfasst von Poul Suadicani und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: King Christian X’s Foundation, Danish Medical Research Council, Danish Heart Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation and genetic susceptibility influence the risk of lung cancer. During recent years, the role of complement as a part of the humoral response has advanced from being considered complementary to being regarded as a central element in innate immunity. C3 complement allotypes F and S have been associated with a number of inflammatory diseases. The C3F allele frequency is approximately 20% in Caucasian populations and the C3S approximately 80%, resulting in the three predominant genotypes FF (4%), FS (32%), and SS (64%). To our knowledge, no studies have investigated if different C3 allotypes or genotypes predict the risk of lung cancer. We tested in a long-term followup of 3,197 men aged 53 to 74 years the hypothesis that risk of lung cancer would depend on C3 complement genotypes. During 16 years, 160 subjects (5.0%) died from lung cancer, 68 men (6.1%) among complement C3 genotypes FS/FF, and 92 men (4.4%) among genotype SS; age-adjusted hazard ratio with 95%CI (HR) was 1.42 (1.04–1.94) and strongest, 2.71 (1.34–5.45), among the oldest fifth. C3 complement genotype variants were significantly associated with lung cancer mortality.

Förderung

  • King Christian X’s Foundation
  • Danish Medical Research Council
  • Danish Heart Foundation
  • Else & Mogens Wedell-Wedellsborg Foundation

Zitieren

APA

Suadicani, P., Hein, H. O., & Gyntelberg, F. (2011). Complement C3 Genotype Variants and Risk of Lung Cancer Mortality. ISRN Pulmonology. https://doi.org/10.5402/2011/423571

Vancouver

Suadicani P, Hein HO, Gyntelberg F. Complement C3 Genotype Variants and Risk of Lung Cancer Mortality. ISRN Pulmonology. 2011. doi:10.5402/2011/423571

BibTeX
@article{Suadicani2011,
  author = {Suadicani, Poul and Hein, Hans Ole and Gyntelberg, Finn},
  title = {Complement C3 Genotype Variants and Risk of Lung Cancer Mortality},
  journal = {ISRN Pulmonology},
  year = {2011},
  doi = {10.5402/2011/423571}
}
Kostenlos starten →